CARDIFF ONCOLOGY, INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
CARDIFF ONCOLOGY, INC. (CRDF) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$5.32 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-11
- CARDIFF ONCOLOGY, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was -$3.48M, a 181.47% decline year-over-year.
- CARDIFF ONCOLOGY, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was -$1.85M.
- CARDIFF ONCOLOGY, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was $940.00K, a 4.68% increase year-over-year.
- CARDIFF ONCOLOGY, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was -$1.96M.
- CARDIFF ONCOLOGY, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $2.20M, a 26.23% decline from fiscal 2024.
- CARDIFF ONCOLOGY, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $2.98M, a 5.44% increase from fiscal 2023.
- CARDIFF ONCOLOGY, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $2.83M, a 110.01% increase from fiscal 2022.
- CARDIFF ONCOLOGY, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $1.35M, a 87.48% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 152 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 155 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 158 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 161 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 164 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 167 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 170 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 173 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 176 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$3.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$5.32M 10-Q · filed 2026-08-11 | -$4.38M derived: sum of 3 quarters · filed 2026-08-11 | -$6.34M derived: sum of 4 quarters · filed 2026-08-11 | |||||||||||||
| 2026-03-31 | -$1.85M 10-Q · filed 2026-05-14 | -$907.00K derived: sum of 2 quarters · filed 2026-05-14 | -$2.87M derived: sum of 3 quarters · filed 2026-05-14 | $1.40M derived: sum of 4 quarters · filed 2026-08-11 | |||||||||||||
| 2025-12-31 | $940.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$1.02M derived: sum of 2 quarters · filed 2026-02-24 | $3.25M derived: sum of 3 quarters · filed 2026-08-11 | $2.20M 10-K · filed 2026-02-24 | |||||||||||||
| 2025-09-30 | -$1.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.31M derived: sum of 2 quarters · filed 2026-08-11 | $1.26M 10-Q · filed 2025-11-06 | $2.16M derived: sum of 4 quarters · filed 2026-08-11 | |||||||||||||
| 2025-06-30 | $4.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $3.22M 10-Q · filed 2026-08-11 | $4.12M derived: sum of 3 quarters · filed 2026-08-11 | $4.12M derived: sum of 4 quarters · filed 2026-08-11 | |||||||||||||
| 2025-03-31 | -$1.04M 10-Q · filed 2026-05-14 | -$147.00K derived: sum of 2 quarters · filed 2026-05-14 | -$148.00K derived: sum of 3 quarters · filed 2026-05-14 | $525.00K derived: sum of 4 quarters · filed 2026-05-14 | |||||||||||||
| 2024-12-31 | $898.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $897.00K derived: sum of 2 quarters · filed 2026-02-24 | $1.57M derived: sum of 3 quarters · filed 2026-02-24 | $2.98M 10-K · filed 2026-02-24 | |||||||||||||
| 2024-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $672.00K derived: sum of 2 quarters · filed 2025-11-06 | $2.09M 10-Q · filed 2025-11-06 | $3.49M derived: sum of 4 quarters · filed 2025-11-06 | |||||||||||||
| 2024-06-30 | $673.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $2.09M 10-Q · filed 2025-07-29 | $3.49M derived: sum of 3 quarters · filed 2025-07-29 | $3.63M derived: sum of 4 quarters · filed 2025-07-29 | |||||||||||||
| 2024-03-31 | $1.42M 10-Q · filed 2025-05-08 | $2.82M derived: sum of 2 quarters · filed 2025-05-08 | $2.95M derived: sum of 3 quarters · filed 2025-05-08 | $4.04M derived: sum of 4 quarters · filed 2025-05-08 | |||||||||||||
| 2023-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $1.54M derived: sum of 2 quarters · filed 2025-02-27 | $2.63M derived: sum of 3 quarters · filed 2025-02-27 | $2.83M 10-K · filed 2025-02-27 | |||||||||||||
| 2023-09-30 | $135.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.23M derived: sum of 2 quarters · filed 2024-11-07 | $1.43M 10-Q · filed 2024-11-07 | $1.45M derived: sum of 4 quarters · filed 2024-11-07 | |||||||||||||
| 2023-06-30 | $1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $1.29M 10-Q · filed 2024-08-08 | $1.32M derived: sum of 3 quarters · filed 2024-08-08 | $1.27M derived: sum of 4 quarters · filed 2024-08-08 | |||||||||||||
| 2023-03-31 | $203.00K 10-Q · filed 2024-05-02 | $226.00K derived: sum of 2 quarters · filed 2024-05-02 | $184.00K derived: sum of 3 quarters · filed 2024-05-02 | $1.55M derived: sum of 4 quarters · filed 2024-05-02 | |||||||||||||
| 2022-12-31 | $23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$19.00K derived: sum of 2 quarters · filed 2024-02-29 | $1.35M derived: sum of 3 quarters · filed 2024-02-29 | $1.35M 10-K · filed 2024-02-29 | |||||||||||||
| 2022-09-30 | -$42.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $1.32M derived: sum of 2 quarters · filed 2023-11-02 | $1.32M 10-Q · filed 2023-11-02 | $2.87M derived: sum of 4 quarters · filed 2023-11-02 | |||||||||||||
| 2022-06-30 | $1.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $1.37M 10-Q · filed 2023-08-09 | $2.92M derived: sum of 3 quarters · filed 2023-08-09 | $3.21M derived: sum of 4 quarters · filed 2023-08-09 | |||||||||||||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-04 | $1.55M derived: sum of 2 quarters · filed 2023-05-04 | $1.84M derived: sum of 3 quarters · filed 2023-05-04 | $2.14M derived: sum of 4 quarters · filed 2023-05-04 | |||||||||||||
| 2021-12-31 | $1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $1.84M derived: sum of 2 quarters · filed 2023-03-02 | $2.14M derived: sum of 3 quarters · filed 2023-03-02 | $719.00K 10-K · filed 2023-03-02 | |||||||||||||
| 2021-09-30 | $291.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $591.00K derived: sum of 2 quarters · filed 2022-11-03 | -$830.00K 10-Q · filed 2022-11-03 | $126.00K derived: sum of 4 quarters · filed 2022-11-03 | |||||||||||||
| 2021-06-30 | $300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$1.12M 10-Q · filed 2022-08-04 | -$165.00K derived: sum of 3 quarters · filed 2022-08-04 | $668.00K derived: sum of 4 quarters · filed 2022-08-04 | |||||||||||||
| 2021-03-31 | -$1.42M 10-Q · filed 2022-05-05 | -$465.00K derived: sum of 2 quarters · filed 2022-05-05 | $368.00K derived: sum of 3 quarters · filed 2022-05-05 | -$234.00K derived: sum of 4 quarters · filed 2022-05-05 | |||||||||||||
| 2020-12-31 | $956.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $1.79M derived: sum of 2 quarters · filed 2022-02-24 | $1.19M derived: sum of 3 quarters · filed 2022-02-24 | $1.28M 10-K · filed 2022-02-24 | $1.28M 10-K · filed 2021-02-25 | ||||||||||||
| 2020-09-30 | $833.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $231.00K derived: sum of 2 quarters · filed 2021-11-04 | $320.00K 10-Q · filed 2021-11-04 | $318.99K 10-Q · filed 2020-11-05 | $937.78K derived: sum of 4 quarters · filed 2021-11-04 | ||||||||||||
| 2020-06-30 | -$602.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$513.00K 10-Q · filed 2021-08-05 | -$514.24K 10-Q · filed 2020-08-11 | $104.78K derived: sum of 3 quarters · filed 2021-08-05 | $555.29K derived: sum of 4 quarters · filed 2021-08-05 | ||||||||||||
| 2020-03-31 | $89.00K 10-Q · filed 2021-05-06 | $88.28K 10-Q · filed 2020-05-07 | $706.78K derived: sum of 2 quarters · filed 2021-05-06 | $1.16M derived: sum of 3 quarters · filed 2021-05-06 | $1.54M derived: sum of 4 quarters · filed 2021-05-06 | ||||||||||||
| 2019-12-31 | $617.78K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $1.07M derived: sum of 2 quarters · filed 2021-02-25 | $1.45M derived: sum of 3 quarters · filed 2021-02-25 | $1.46M 10-K · filed 2021-02-25 | |||||||||||||
| 2019-09-30 | $450.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $833.92K derived: sum of 2 quarters · filed 2020-11-05 | $837.55K 10-Q · filed 2020-11-05 | $669.00K derived: sum of 4 quarters · filed 2020-11-05 | |||||||||||||
| 2019-06-30 | $383.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $387.05K 10-Q · filed 2020-08-11 | $218.49K derived: sum of 3 quarters · filed 2020-08-11 | -$37.17K derived: sum of 4 quarters · filed 2020-08-11 | |||||||||||||
| 2019-03-31 | $3.63K 10-Q · filed 2020-05-07 | -$164.92K derived: sum of 2 quarters · filed 2020-05-07 | -$420.58K derived: sum of 3 quarters · filed 2020-05-07 | $167.16K derived: sum of 4 quarters · filed 2020-05-07 | |||||||||||||
| 2018-12-31 | -$168.55K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$424.22K derived: sum of 2 quarters · filed 2020-02-27 | $163.53K derived: sum of 3 quarters · filed 2020-02-27 | $214.48K 10-K · filed 2020-02-27 | $236.48K 10-K · filed 2019-03-06 | ||||||||||||
| 2018-09-30 | -$255.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $332.08K derived: sum of 2 quarters · filed 2019-11-07 | $383.04K 10-Q · filed 2019-11-07 | -$649.17K derived: sum of 4 quarters · filed 2019-11-07 | |||||||||||||
| 2018-06-30 | $587.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $638.70K 10-Q · filed 2019-08-08 | -$393.50K derived: sum of 3 quarters · filed 2019-08-08 | -$2.58M derived: sum of 4 quarters · filed 2019-08-08 | |||||||||||||
| 2018-03-31 | $50.96K 10-Q · filed 2019-05-07 | -$981.25K derived: sum of 2 quarters · filed 2019-05-07 | -$3.17M derived: sum of 3 quarters · filed 2019-05-07 | -$2.53M derived: sum of 4 quarters · filed 2019-05-07 | |||||||||||||
| 2017-12-31 | -$1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | -$3.22M derived: sum of 2 quarters · filed 2019-03-06 | -$2.58M derived: sum of 3 quarters · filed 2019-03-06 | -$2.94M 10-K · filed 2019-03-06 | |||||||||||||
| 2017-09-30 | -$2.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$1.55M derived: sum of 2 quarters · filed 2018-11-07 | -$1.91M 10-Q · filed 2018-11-07 | -$2.24M derived: sum of 4 quarters · filed 2018-11-07 | |||||||||||||
| 2017-06-30 | $641.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $280.52K 10-Q · filed 2018-08-03 | -$52.40K derived: sum of 3 quarters · filed 2018-08-03 | $956.21K derived: sum of 4 quarters · filed 2018-08-03 | |||||||||||||
| 2017-03-31 | -$360.58K 10-Q · filed 2018-05-08 | -$693.49K derived: sum of 2 quarters · filed 2018-05-08 | $315.11K derived: sum of 3 quarters · filed 2018-05-08 | $724.30K derived: sum of 4 quarters · filed 2018-05-08 | |||||||||||||
| 2016-12-31 | -$332.92K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $675.69K derived: sum of 2 quarters · filed 2018-02-26 | $1.08M derived: sum of 3 quarters · filed 2018-02-26 | $2.16M 10-K · filed 2018-02-26 | |||||||||||||
| 2016-09-30 | $1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $1.42M derived: sum of 2 quarters · filed 2017-11-09 | $2.49M 10-Q · filed 2017-11-09 | $2.24M derived: sum of 4 quarters · filed 2017-11-09 | |||||||||||||
| 2016-06-30 | $409.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $1.48M 10-Q · filed 2017-08-09 | $1.23M derived: sum of 3 quarters · filed 2017-08-09 | $1.81M derived: sum of 4 quarters · filed 2017-08-09 | |||||||||||||
| 2016-03-31 | $1.07M 10-Q · filed 2017-05-10 | $817.41K derived: sum of 2 quarters · filed 2017-05-10 | $1.41M derived: sum of 3 quarters · filed 2017-05-10 | $1.82M derived: sum of 4 quarters · filed 2017-05-10 | |||||||||||||
| 2015-12-31 | -$254.93K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $333.20K derived: sum of 2 quarters · filed 2017-03-15 | $745.07K derived: sum of 3 quarters · filed 2017-03-15 | $361.43K 10-K · filed 2017-03-15 | |||||||||||||
| 2015-09-30 | $588.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $1.00M derived: sum of 2 quarters · filed 2016-11-09 | $616.37K 10-Q · filed 2016-11-09 | $711.82K derived: sum of 4 quarters · filed 2017-03-15 | |||||||||||||
| 2015-06-30 | $411.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $28.23K 10-Q · filed 2016-08-04 | $123.69K derived: sum of 3 quarters · filed 2017-03-15 | $507.93K derived: sum of 4 quarters · filed 2017-03-15 | |||||||||||||
| 2015-03-31 | -$383.64K 10-Q · filed 2016-05-10 | -$288.19K derived: sum of 2 quarters · filed 2017-03-15 | $96.05K derived: sum of 3 quarters · filed 2017-03-15 | $234.18K derived: sum of 4 quarters · filed 2017-03-15 | |||||||||||||
| 2014-12-31 | $95.45K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $479.69K derived: sum of 2 quarters · filed 2017-03-15 | $617.82K derived: sum of 3 quarters · filed 2017-03-15 | $632.30K 10-K · filed 2017-03-15 | |||||||||||||
| 2014-09-30 | $384.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $522.37K derived: sum of 2 quarters · filed 2015-11-09 | $536.84K 10-Q · filed 2015-11-09 | $632.90K 10-Q · filed 2014-11-06 | $1.13M derived: sum of 4 quarters · filed 2016-03-10 | ||||||||||||
| 2014-06-30 | $138.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $152.60K 10-Q · filed 2015-08-10 | $746.22K derived: sum of 3 quarters · filed 2016-03-10 | $578.51K derived: sum of 4 quarters · filed 2016-03-10 | |||||||||||||
| 2014-03-31 | $14.48K 10-Q · filed 2015-05-05 | $608.09K derived: sum of 2 quarters · filed 2016-03-10 | $440.39K derived: sum of 3 quarters · filed 2016-03-10 | $753.62K derived: sum of 4 quarters · filed 2016-03-10 | $1.75M 10-Q · filed 2014-05-12 | ||||||||||||
| 2013-12-31 | $593.61K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $425.91K derived: sum of 2 quarters · filed 2016-03-10 | $739.14K derived: sum of 3 quarters · filed 2016-03-10 | $1.06M 10-K · filed 2016-03-10 | $1.73M 10-K · filed 2014-03-17 | ||||||||||||
| 2013-09-30 | -$167.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $145.52K derived: sum of 2 quarters · filed 2014-11-06 | $462.08K 10-Q · filed 2014-11-06 | $425.35K derived: sum of 4 quarters · filed 2015-03-12 | $1.14M 10-Q · filed 2013-11-14 | ||||||||||||
| 2013-06-30 | $313.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $629.78K 10-Q · filed 2014-08-07 | $593.05K derived: sum of 3 quarters · filed 2015-03-12 | $105.43K derived: sum of 4 quarters · filed 2015-03-12 | $1.31M 10-Q · filed 2013-08-14 | ||||||||||||
| 2013-03-31 | $316.55K 10-Q · filed 2014-05-12 | $279.82K derived: sum of 2 quarters · filed 2015-03-12 | -$207.79K derived: sum of 3 quarters · filed 2015-03-12 | -$514.48K derived: sum of 4 quarters · filed 2015-03-12 | $995.17K 10-Q · filed 2013-05-14 | ||||||||||||
| 2012-12-31 | -$36.73K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | -$524.35K derived: sum of 2 quarters · filed 2015-03-12 | -$831.04K derived: sum of 3 quarters · filed 2015-03-12 | -$737.75K 10-K · filed 2015-03-12 | $678.62K 10-K · filed 2013-04-01 | ||||||||||||
| 2012-09-30 | -$487.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$794.30K derived: sum of 2 quarters · filed 2013-11-14 | -$701.02K 10-Q · filed 2013-11-14 | -$386.60K derived: sum of 4 quarters · filed 2014-03-17 | $715.35K 10-Q · filed 2012-11-14 | ||||||||||||
| 2012-06-30 | -$306.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$213.41K 10-Q · filed 2013-08-14 | $101.01K derived: sum of 3 quarters · filed 2014-03-17 | $188.94K derived: sum of 4 quarters · filed 2014-03-17 | $1.20M 10-Q · filed 2012-08-14 | ||||||||||||
| 2012-03-31 | $93.29K 10-Q · filed 2013-05-14 | $407.71K derived: sum of 2 quarters · filed 2014-03-17 | $495.63K derived: sum of 3 quarters · filed 2014-03-17 | $422.96K derived: sum of 4 quarters · filed 2014-03-17 | $1.51M 10-Q · filed 2012-05-15 | ||||||||||||
| 2011-12-31 | $314.42K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $402.35K derived: sum of 2 quarters · filed 2014-03-17 | $329.67K derived: sum of 3 quarters · filed 2014-03-17 | $504.19K 10-K · filed 2014-03-17 | |||||||||||||
| 2011-09-30 | $87.93K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $15.25K derived: sum of 2 quarters · filed 2012-11-14 | $189.77K 10-Q · filed 2012-11-14 | ||||||||||||||
| 2011-06-30 | -$72.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $101.84K 10-Q · filed 2012-08-14 | |||||||||||||||
| 2011-03-31 | $174.51K 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |